surrogate endpoints - Robuta Search

https://iris.unibocconi.it/handle/11565/4040631 Raising the bar for using surrogate endpoints in drug regulation and health technology assessment raising the bar health technology assessment surrogate endpoints drug regulation using https://pmc.ncbi.nlm.nih.gov/articles/PMC5520356/ Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions,... Surrogate outcomes are not intrinsically beneficial to patients, but are designed to be easier and faster to measure than clinically meaningful outcomes. The... surrogate endpoints clinical decisions oncology acceptable regulatory https://www.clinicaltrialsarena.com/analyst-comment/surrogate-endpoints-blood-cancer-trials/ Use of surrogate endpoints in blood cancer trials can speed up approvals Mar 2, 2023 - Alternative endpoints in blood cancer trials could improve comparisons between experimental treatments and speed up drug approval. surrogate endpoints blood cancer speed up use trials https://www.raps.org/resource/surrogate-endpoints-table-fda-seeks-feedback.html Surrogate Endpoints Table: FDA Seeks Feedback | RAPS The US Food and Drug Administration (FDA) on Monday sought feedback on a table of surrogate endpoints that the agency is developing. surrogate endpoints table fda seeks feedback https://oncodaily.com/blog/bishal-gyawali-253325 Bishal Gyawali: Surrogate endpoints in cancer drug trials - OncoDaily Mar 10, 2025 - Bishal Gyawali: Surrogate endpoints in cancer drug trials / Bishal Gyawali, cancer, Medscape, OncoDaily, Oncology, Skills Lab Video surrogate endpoints drug trials cancer oncodaily https://www.ispor.org/vih-articles/Volume-26--Supplemental-Issue-12S/HTA323-Analyzing-Historic-Health-Technology-Assessments-(HTAs)--Surrogate-Endpoints-(SEs)-in-the-Interstitial-Pneumonia-With-Autoimmune-Features-(IPF)-Interstitial-Lung-Disease-(ILD)-Therapeutic-Domain HTA323 Analyzing Historic Health Technology Assessments (HTAs): Surrogate Endpoints (SEs) in the... health technology assessments surrogate endpoints analyzing historic https://lowninstitute.org/cancer-drug-approvals-with-new-surrogate-endpoints-are-common-and-concerning/ Cancer drug approvals with new surrogate endpoints are common and concerning - Lown Institute May 5, 2020 - How is the FDA measuring success when it comes to approval for new cancer drugs? drug approvals surrogate endpoints are common cancer new https://boa.unimib.it/handle/10281/466668 Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint... surrogate endpoints clinical trials immune checkpoint overall survival https://pure.eur.nl/en/publications/surrogate-endpoints-for-late-kidney-transplantation-failure/ Surrogate Endpoints for Late Kidney Transplantation Failure - Erasmus University Rotterdam erasmus university rotterdam surrogate endpoints kidney transplantation late failure https://www.frontierspartnerships.org/journals/transplant-international/articles/10.3389/ti.2022.10136/full Frontiers Publishing Partnerships | Surrogate Endpoints for Late Kidney Transplantation Failure In kidney transplant recipients, late graft failure is often multifactorial. In addition, primary endpoints in kidney transplantation studies seek to demonst... publishing partnerships surrogate endpoints kidney transplantation frontiers late https://cris.maastrichtuniversity.nl/en/publications/an-information-theoretic-approach-to-surrogate-marker-evaluation-/ An information-theoretic approach to surrogate-marker evaluation with failure time endpoints -... information approach surrogate marker evaluation